XML 46 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Valuation Techniques For Market Condition Stock Option Award By Vesting Tranche
The fair value and derived service periods calculated for this market condition stock option award by vesting tranche for the market condition stock option awards granted in September 2016 were as follows:
 
Grant Date
Fair Value
Per Share
 
Derived Service
Period
(in Years)
$4.00 market condition tranche
$
0.32

 
5.1
$5.00 market condition tranche
$
0.31

 
5.5
$6.00 market condition tranche
$
0.30

 
5.9

The fair value and derived service periods calculated for this market condition stock option award by vesting tranche for the market condition stock option awards granted in June 2015 were as follows:

 
Grant Date
Fair Value
Per Share
 
Derived Service
Period
(in Trading Days)
$4.00 market condition tranche
$
1.95

 
151
$5.00 market condition tranche
$
1.95

 
262
$6.00 market condition tranche
$
1.99

 
362
Service-Based Stock Option Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Stock Options, Activity
A summary of the service-based stock option activity of the Company's Equity Plan as of December 30, 2017 and changes during the fiscal year then ended is presented below:
 
 
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
Outstanding at December 31, 2016
212,762

 
$
6.91

 
 
 
 
Forfeited/cancelled
(105,262
)
 
$
10.92

 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at December 30, 2017
107,500

 
$
2.98

 
7.1 years
 
$

 
 
 
 
 
 
 
 
Options vested and expected to vest at December 30, 2017
100,625

 
$
3.05

 
7.0 years
 
$

 
 
 
 
 
 
 
 
Options exercisable at December 30, 2017
69,999

 
$
3.48

 
6.7 years
 
$

Schedule of Nonvested Share Activity
A summary of the status of service-based non-vested share awards issued under the Equity Plan as of December 30, 2017 and changes during the fiscal year then ended is presented below: 
 
Shares
 
Weighted
 Average
Grant Date
Fair Value per
 share
Outstanding at December 31, 2016
172,422

 
$
0.71

Granted
140,000

 
$
0.95

Vested
(172,422
)
 
$
0.71

Outstanding at December 30, 2017
140,000

 
$
0.95

Market Condition Stock Option Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Stock Options, Activity
A summary of the market condition stock option activity under the Equity Plan, as of December 30, 2017 and changes during the fiscal year then ended is presented below:
 
 
Shares
 
Weighted
 Average
 Exercise
 Price
Outstanding at December 31, 2016
325,000

 
$
2.54

 
 
 
 
Granted

 
$

 
 
 
 
Outstanding at December 30, 2017
325,000

 
$
2.54

 
 
 
 
Options vested and expected to vest at December 30, 2017
325,000

 
$
2.54

 
 
 
 
Options exercisable at December 30, 2017

 
$

Performance Based Non vested Share Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Share Activity
Performance-Based Non-vested Share Awards - A summary of the status of performance-based non-vested share awards issued under the Equity Plan as of December 30, 2017 and changes during the fiscal year then ended is presented below:  
 
Shares
 
Weighted
 Average
Grant Date
Fair Value per
 share
Outstanding at December 31, 2016
172,657

 
$
3.14

Vested
(31,435
)
 
$
3.17

Forfeited
(141,222
)
 
$
3.14

Outstanding at December 30, 2017

 
$

Supplemental Stock Plan 2000 [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Stock Options, Activity
A summary of the option activity under the Company's Supplemental Stock Plan as of December 30, 2017 and changes during the fiscal year then ended is presented below:
 
 
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
Outstanding at December 31, 2016
30,100

 
$
11.06

 
 
 
 

Forfeited/cancelled
(22,400
)
 
$
11.61

 
 
 
 

 
 
 
 
 
 
 
 
Outstanding at December 30, 2017
7,700

 
$
9.45

 
0.2 years
 
$

 
 
 
 
 
 
 
 
Options vested and exercisable at December 30, 2017
7,700

 
$
9.45

 
0.2 years
 
$